Meeder Asset Management Inc Amgen Inc Transaction History

Meeder Asset Management Inc

$1.48 Billion
Q3 2024

A detailed history of Meeder Asset Management Inc transactions in Amgen Inc stock. As of the latest transaction made, Meeder Asset Management Inc holds 53,443 shares of AMGN stock, worth $14.1 Million. This represents 1.16% of its overall portfolio holdings.

Number of Shares

53,443

Previous 46,608 14.66%

Holding current value

$14.1 Million

Previous $14.6 Million 18.25%

% of portfolio

1.16%

Previous 1.03%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$309.38 - $337.38 $2.11 Million - $2.31 Million	6,835 Added 14.66%	53,443 $17.2 Million
Q2 2024 Aug 08, 2024	BUY	$262.75 - $319.31 $11.1 Million - $13.5 Million	42,225 Added 963.38%	46,608 $14.6 Million
Q1 2024 May 07, 2024	SELL	$268.87 - $324.56 $16.2 Million - $19.5 Million	-60,228 Reduced 93.22%	4,383 $1.25 Million
Q4 2023 Jan 25, 2024	BUY	$255.7 - $288.46 $16 Million - $18.1 Million	62,589 Added 3095.4%	64,611 $18.6 Million
Q3 2023 Nov 13, 2023	SELL	$218.65 - $271.46 $10.2 Million - $12.7 Million	-46,768 Reduced 95.86%	2,022 $543,000
Q2 2023 Aug 11, 2023	BUY	$214.27 - $253.37 $4.47 Million - $5.29 Million	20,876 Added 74.79%	48,790 $10.8 Million
Q1 2023 May 15, 2023	BUY	$225.79 - $275.2 $1.06 Million - $1.29 Million	4,705 Added 20.27%	27,914 $6.75 Million
Q4 2022 Feb 14, 2023	SELL	$229.03 - $291.01 $9.61 Million - $12.2 Million	-41,947 Reduced 64.38%	23,209 $6.1 Million
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $1.36 Million - $1.53 Million	6,046 Added 10.23%	65,156 $14.7 Million
Q2 2022 Aug 08, 2022	BUY	$230.71 - $256.74 $830,094 - $923,750	3,598 Added 6.48%	59,110 $14.4 Million
Q1 2022 May 10, 2022	BUY	$219.27 - $242.57 $12.2 Million - $13.5 Million	55,512 New	55,512 $13.4 Million
Q4 2021 Feb 11, 2022	SELL	$198.88 - $227.6 $8.44 Million - $9.66 Million	-42,439 Closed	0 $0
Q3 2021 Nov 08, 2021	SELL	$212.27 - $248.7 $108,257 - $126,837	-510 Reduced 1.19%	42,439 $9.03 Million
Q2 2021 Aug 09, 2021	BUY	$233.58 - $259.14 $97,402 - $108,061	417 Added 0.98%	42,949 $10.5 Million
Q1 2021 Apr 28, 2021	BUY	$221.91 - $258.6 $7.86 Million - $9.16 Million	35,432 Added 499.04%	42,532 $10.6 Million
Q4 2020 Feb 09, 2021	SELL	$216.38 - $257.67 $7.89 Million - $9.39 Million	-36,455 Reduced 83.7%	7,100 $1.63 Million
Q3 2020 Nov 02, 2020	SELL	$234.65 - $260.95 $1.73 Million - $1.92 Million	-7,353 Reduced 14.44%	43,555 $11.1 Million
Q2 2020 Aug 11, 2020	SELL	$197.81 - $242.74 $194,051 - $238,127	-981 Reduced 1.89%	50,908 $12 Million
Q1 2020 May 15, 2020	SELL	$182.24 - $241.7 $29,340 - $38,913	-161 Reduced 0.31%	51,889 $10.5 Million
Q4 2019 Feb 13, 2020	SELL	$189.21 - $243.2 $25,164 - $32,345	-133 Reduced 0.25%	52,050 $12.5 Million
Q3 2019 Oct 17, 2019	BUY	$174.11 - $208.62 $157,395 - $188,592	904 Added 1.76%	52,183 $10.1 Million
Q2 2019 Aug 05, 2019	BUY	$166.7 - $195.41 $877,842 - $1.03 Million	5,266 Added 11.44%	51,279 $9.45 Million
Q1 2019 Apr 16, 2019	SELL	$180.87 - $203.88 $30,747 - $34,659	-170 Reduced 0.37%	46,013 $8.74 Million
Q4 2018 Jan 17, 2019	SELL	$178.4 - $208.25 $36,393 - $42,483	-204 Reduced 0.44%	46,183 $8.99 Million
Q3 2018 Nov 02, 2018	BUY	$185.29 - $208.89 $928,302 - $1.05 Million	5,010 Added 12.11%	46,387 $0
Q2 2018 Jul 24, 2018	SELL	$166.05 - $186.51 $360,328 - $404,726	-2,170 Reduced 4.98%	41,377 $0
Q1 2018 May 03, 2018	BUY	$169.43 - $198.0 $640,275 - $748,242	3,779 Added 9.5%	43,547 $7.42 Million
Q4 2017 Feb 02, 2018	BUY	$168.79 - $188.59 $365,092 - $407,920	2,163 Added 5.75%	39,768 $6.91 Million
Q3 2017 Oct 20, 2017	BUY	$167.29 - $191.0 $6.29 Million - $7.18 Million	37,605	37,605 $7.01 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Meeder Asset Management Inc with notifications on news.

Account

Meeder Asset Management Inc Amgen Inc Transaction History